Daily SPAC Update – July 31, 2024

KRNL + AIRO Vote. BHAC Extension Vote. PWUP LOI with Aspire Biopharma. TRTLF Tortoiseecofin Disputes Deal Termination.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

MERGER VOTES
KRNL + AIRO

SPAC DEAL & EXTENSION VOTES SET
IVCA – Investcorp India Acquisition Corp * EXTENSION VOTE SET: Aug 08, 2024 * trust $11.40

EXTENSION VOTES
BHAC – FOCUS IMPACT BH3 ACQUISITION CO * vote July 23, 2024 -> extend to February 7, 2025

OTHER SPAC NEWS
PWUP – PowerUp Acquisition Corp. * LOI w/ Aspire Biopharma, Inc.
TRTLF – TORTOISEECOFIN ACQUISITION CORP III * Disputed deal termination
AACI – ARMADA ACQUISITION CORP I * Vote Adjourn
BHAC – FOCUS IMPACT BH3 ACQUISITION CO * Vote Adjourn
ZLS – ZALATORIS II ACQUISITION CORP * Vote Postponed

DeSPACs
PEGR -> PITA on Jul 30

SEPARATE WARRANTS/RIGHTS
ALF on Aug 01

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-07-23: PWUP + Visiox Pharmaceuticals

YESTERDAY’S TOP SPAC GAINERS
5.30% ~ $ 13.71 | NPAB – New Providence Acquisition Corp. II (Pre-Deal)
4.00% ~ $ 9.11 | AACI – Armada Acquisition Corp. I (Announced)
3.30% ~ $ 11.89 | IMAQ – International Media Acquisition Corp. (Pre-Deal)
2.88% ~ $ 11.42 | QOMO – Qomolangma Acquisition Corp. (Pre-Deal)
2.59% ~ $ 16.22 | ADRT – Ault Disruptive Technologies Corp (Announced)

YESTERDAY’S TOP SPAC LOSERS
-25.60% ~ $ 5.87 | CETU – Cetus Capital Acquisition Corp. (Announced)
-9.27% ~ $ 8.96 | ARYD – ARYA Sciences Acquisition Corp IV (Announced)
-6.90% ~ $ 12.01 | PTWO – Pono Capital Two, Inc. (Announced)
-5.61% ~ $ 11.10 | BHAC – Focus Impact BH3 Acquisition Company (Announced)
-4.14% ~ $ 10.64 | KRNL – Kernel Group Holdings, Inc. (Announced)

 

Recent Analysis

2026 Proxy Season Scorecard: Six Say-on-Pay Failures, AI Lands on Mega-Cap Ballots, and the Anti-ESG Pile-Up

Through May 21, 2026, U.S. public-company shareholders rejected six annual-meeting Say-on-Pay packages outright, voted against 18 directors at 14 companies, and crushed dozens of mega-cap shareholder proposals at sub-3% support. Plus: AI proposals filed at Alphabet, Meta, Walmart, and IBM; the split verdict on special-meeting rights; the activist-vote scorecard from four 2026 director-slate contests.

Weekly Recap: MO, OHI, WEN Rewire the C-Suite — May 22, 2026

Succession moved from emergency cleanup to portfolio rotation this week, with 24 CEO changes and 21 CFO changes across the tracked C-suite. Altria paired a CEO handoff with a CFO change, Omega Healthcare reset three senior finance and operating seats, and Wendy’s went back to the CEO market for the third time in three years.

SPAC Market Update May 22, 2026: BRKH, PECE Price $140M of SPAC IPOs

BurTech Acquisition Corp II (BRKH) and Peace Acquisition Corp. (PECE) priced 2 SPAC IPOs on May 22, 2026, raising $140M combined. BRKH targets real estate, infrastructure and lifestyle brands; PECE targets businesses across Asia, excluding Mainland China, Hong Kong and Macau.

SPAC Market Update May 22, 2026: BRKH, PECE Price $140M of SPAC IPOs

BurTech Acquisition Corp II (BRKH) and Peace Acquisition Corp. (PECE) priced 2 SPAC IPOs on May 22, 2026, raising $140M combined. BRKH targets real estate, infrastructure and lifestyle brands; PECE targets businesses across Asia, excluding Mainland China, Hong Kong and Macau.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.